Medical Engineering & Physics
Volume 31, Issue 7 , Pages 742-751 , September 2009

Cardiovascular cavitation

Received 19 December 2008 ,Revised 12 March 2009 ,Accepted 15 March 2009.

References 

  1. Polak JF. Ultrasound energy and the dissolution of thrombus. N Engl J Med. 2004;351:2154–2155
  2. Everbach EC, Francis CW. Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1MHz. Ultrasound Med Biol. 2000;26:1153–1160
  3. Hamm CW, Reimers J, Köster R, Terres W, Stiel GM, Koschyk DH, et al. Coronary ultrasound thrombolysis in a patient with acute myocardial infarction. Lancet. 1994;343:605–606
  4. Rosenschein U, Gaul G, Erbel R, Amann F, Velasquez D, Stoerger H, et al. Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis?. Circulation. 1999;99:26
  5. Rees MR, Michalis LK. Activated-guidewire technique for treating chronic coronary artery occlusion. Lancet. 1995;346:943–944
  6. Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation. 1996;94:3334–3340
  7. Alkan-Onyuksel H, Demos SM, Lanza GM, Vonesh MJ, Klegerman ME, Kane BJ, et al. Development of inherently echogenic liposomes as an ultrasonic contrast agent. J Pharm Sci. 1996;85:486–490
  8. Meza M, Greener Y, Hunt R, Perry B, Revall S, Barbee W, et al. Myocardial contrast echocardiography: reliable safe and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent. Am Heart J. 1996;132:871–881
  9. Huang SL, Hamilton AJ, Pozharski E, Nagaraj A, Klegerman ME, McPherson DD, et al. Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol. 2002;28:339–348
  10. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol. 1968;3:356–366
  11. Nanda NC, Schlief R, Goldberg BB. Advances in echo imaging using contrast enhancement. Dordrecht: Kluwer; 1997;
  12. Bouakaz A, de Jong N, Cachard C, Jouini K. On the effect of lung filtering and cardiac pressure on the standard properties of ultrasound contrast agent. Ultrasonics. 1998;36:703–708
  13. Mayer S, Grayburn PA. Myocardial contrast agents: recent advances and future directions. Prog Cardiovasc Dis. 2001;44:33–44
  14. Keller MW, Feinstein SB, Watson DD. Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation. Am Heart J. 1987;114:570–575
  15. Raisinghani A, DeMaria AN. Physical principles of microbubble ultrasound contrast agents. Am J Cardiol. 2002;90:3J–7J
  16. Klibanov AL. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications. Invest Radiol. 2006;41:354–362
  17. von Bibra H, Voigt JU, Froman M, Bone D, Wranne B, Juhlin-Dannfeldt A. Interaction of microbubbles with ultrasound. Echocardiography. 1999;16:733–741
  18. Firschke C, Lindner JR, Wei K, Goodman NC, Skyba DM, Kaul S. Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second-generation echocardiographic contrast agent. Circulation. 1997;96:959–967
  19. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol. 2000;35:58–71
  20. Strobel D, Kleinecke C, Hansler J, Frieser M, Handl T, Hahn EG, et al. Contrast-enhanced sonography for the characterization of hepatocellular carcinomas-correlation with histological differentiation. Ultraschall Med. 2005;26:270–276
  21. Shi WT, Forsberg F, Hall AL, Chia RY, Liu JB, Miller S, et al. Subharmonic imaging with microbubble contrast agents: initial results. Ultrason Imaging. 1999;21:79–94
  22. Basude R, Wheatley MA. Generation of ultraharmonics in surfactant based ultrasound contrast agents: use and advantages. Ultrasonics. 2001;39:437–444
  23. Rainbird AJ, Mulvagh SL, Oh JK, McCully RB, Klarich KW, Shub C, et al. Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr. 2001;14378–14385
  24. Unger EC, McCreery TP, Sweitzer RH, Shen DK, Wu GL. In vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol. 1998;81:58G–61G
  25. Ferrara KW, Merritt CRB, Burns PN, Foster FS, Mattrey RF, Wickline SA. Evaluation of tumor angiogenesis with US: imaging Doppler and contrast agents. Acad Radiol. 2000;7:824–839
  26. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound induced destruction of microbubbles administrated as a contrast venous infusion. Circulation. 1998;97:473–483
  27. Leong-Poi H, Le E, Rim SJ, Sakuma T, Kaul S, Wei K. Quantification of myocardial perfusion and determination of coronary stenosis severity during hyperemia using real-time myocardial contrast echocardiography. J Am Soc Echocardiogr. 2001;14:1173–1182
  28. Hansen A, Bekeredjian R, Filusch A, Wolf D, Gross ML, Mueller S, et al. Cardioprotective effects of the novel selective endothelin-A receptor antagonist BSF 461314 in ischemia-reperfusion injury. J Am Soc Echocardiogr. 2005;18:1213–1220
  29. Kaul S. Myocardial contrast echocardiography: basic principles. Prog Cardiovasc Dis. 2001;44:1–11
  30. Blomley MJ, Cooke JC, Unger EC, Monaghan MJ, Crosgrove DO. Microbubble contrast agents: anew era in ultrasound. BMJ. 2001;322:1222–1225
  31. Dijkmans PA, Juffermans LJM, Musters RJP, van Wamel A, ten Cate FJ, van Gilst W, et al. Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiogr. 2004;5:245–256
  32. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov. 2004;3:527–532
  33. Shohet RV, Chen S, Zhou YT, Wang Z, Meidell RS, Unger RH, et al. Echocardiographic destruction of albumin micro-bubbles directs gene delivery to the myocardium. Circulation. 2000;101:2554–2556
  34. Erikson JM, Freeman GL, Chandrasekar B. Ultrasound-targeted antisense oligonucleotide attenuates ischemia/reperfusion-induced myocardial tumor necrosis factor-alpha. J Mol Cell Cardiol. 2003;35:119–130
  35. Unger EC, Matsunaga TO, McCreery T, Schumann P, Sweitzer R, Quigley R. Therapeutic applications of microbubbles. Eur J Radiol. 2002;42:160–168
  36. Lawrie A, Brisken AF, Francis SE, Cumberland DC, Crossman DC, Newman CM. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther. 2000;7:2023–2027
  37. Pislaru SV, Pislaru C, Kinnick RR, Singh R, Gulati R, Greenleaf JF, et al. Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities. Eur Heart J. 2003;24:1690–1698
  38. Song J, Chappell JC, Qi M, VanGieson EJ, Kaul S, Price RJ. Influence of injection site microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J Am Coll Cardiol. 2002;39:726–731
  39. Kondo I, Ohmori K, Oshita A, Takeuchi H, Fuke S, Shinomiya K, et al. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a “functional” gene using ultrasonic microbubble destruction. J Am Coll Cardiol. 2004;44:644–653
  40. Taniyama Y, Tachibana K, Hiraoka K, Namba T, Yamasaki K, Hashiya N, et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation. 2002;105:1233–1239
  41. Hashiya N, Aoki M, Tachibana K, Taniyama Y, Yamasaki K, Hiraoka K, et al. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model. Biochem Biophys Res Commun. 2004;317:508–514
  42. Hynynen K, McDannold N, Vykhodtseva N, Jolesz F. Noninvasive MR imaging-guided focal opening of the blood–brain barrier in rabbits. Radiology. 2001;220:640–646
  43. Mukherjee D, Wong J, Griffin B, Ellis SG, Porter T, Sen S, et al. Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J Am Coll Cardiol. 2000;35:1678–1686
  44. Bekeredjian R, Chen S, Grayburn PA, Shohet RV. Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol. 2005;31:687–691
  45. Zhou Z, Mukherjee D, Wang K, Zhou X, Tarakji K, Ellis K, et al. Induction of angiogenesis in a canine model of chronic myocardial ischemia with intravenous infusion of vascular endothelial growth factor (VEGF) combined with ultrasound energy and echo contrast agent. J Am Coll Cardiol. 2002;39:396
  46. Zhigang W, Zhiyu L, Haitao R, Hong R, Qunxia Z, Ailong H, et al. Ultrasound-mediated microbubble destruction enhances VEGF gene delivery to the infarcted myocardium in rats. Clin Imaging. 2004;28:395–398
  47. Tiukinhoy SD, Khan AA, Huang S, Klegerman ME, MacDonald RC, McPherson DD. Novel echogenic drug-immunoliposomes for drug delivery. Invest Radiol. 2004;39:104–110
  48. van Wamel A, Bouakaz A, Bernard B, ten Cate F, de Jong N. Radionuclide tumour therapy with ultrasound contrast microbubbles. Ultrasonics. 2004;42:903–906
  49. Postema M, van Wamel A, Lancee CT, de Jong N. Ultrasound-induced encapsulated microbubble phenomena. Ultrasound Med Biol. 2004;30:827–840
  50. Suslick KS. Ultrasound: its chemical physical and biological effects. New York: VCH; 1988;
  51. Chomas JE, Dayton PA, May D, Allen J, Klibanov A, Ferrara K. Optical observation of contrast agent destruction. Appl Phys Lett. 2000;77:1056–1058
  52. de Jong N, Frinking PJA, Bouakaz A, Goorden M, Schourmans T, Jingping X, et al. Optical imaging of contrast agent microbubbles in an ultrasound field with a 100-MHz camera. Ultrasound Med Biol. 2000;26:487–492
  53. Bouakaz A, Versluis M, de Jong N. High-speed optical observations of contrast agent destruction. Ultrasound Med Biol. 2005;31:391–399
  54. Chomas JE, Dayton PA, May D, Allen J, Klibanov A, Ferrara K. Threshold of fragmentation for ultrasonic contrast agents. J Biomed Opt. 2001;6:141–150
  55. Bloch SH, Wan M, Dayton PA, Ferrara KW. Optical observation of lipid- and polymer-shelled ultrasound microbubble contrast agents. Appl Phys Lett. 2004;84:631–633
  56. Zheng H, Dayton PA, Caskey C, Zhao S, Qin S, Ferrara KW. Ultrasound-driven microbubble oscillation and translation within small phantom vessels. Ultrasound Med Biol. 2007;33:1978–1987
  57. Brujan EA. Collapse of cavitation bubbles in blood. Europhys Lett. 2000;50:175–181
  58. Brujan EA, Ikeda T, Matsumoto Y. On the pressure of cavitation bubbles. Exp Therm Fluid Sci. 2008;32:1188–1191
  59. Brujan EA. The role of cavitation microjets in the therapeutic applications of ultrasound. Ultrasound Med Biol. 2004;30:381–387
  60. Brujan EA, Ikeda T, Matsumoto Y. Jet formation and shock wave emission during collapse of ultrasound-induced cavitation bubbles and their role in the therapeutic applications of high-intensity focused ultrasound. Phys Med Biol. 2005;50:4797–4809
  61. Prentice P, Cuschieri A, Dholakia K, Prausnitz M, Campbell P. Membrane disruption by optically controlled microbubble cavitation. Nat Phys. 2005;1:107–110
  62. Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet. 2002;353:1409
  63. Wu J. Temperature rise generated by ultrasound in the presence of contrast agent. Ultrasound Med Biol. 1998;24:267–274
  64. Kondo T, Misik V, Riesz P. Effect of gas-containing microspheres and echo contrast agents on free radical formation by ultrasound. Free Radic Biol Med. 1998;25:605–612
  65. Basta G, Venneri L, Lazzerini G, Pasanisi E, Pianelli M, Vesentini N, et al. In vitro modulation of intracellular oxidative stress of endothelial cells by diagnostic cardiac ultrasound. Cardiovasc Res. 2003;58:156–161
  66. Deng CX, Sieling F, Pan H, Cui J. Ultrasound-induced cell membrane porosity. Ultrasound Med Biol. 2004;30:519–526
  67. Ohl CD, Arora M, Ikink R, de Jong N, Versluis M, Delius M, et al. Sonoporation from jetting cavitation bubbles. Biophys J. 2006;91:4285–4295
  68. Wu J, Pepe J, Dewitt W. Nonlinear behaviors of contrast agents relevant to diagnostic and therapeutic applications. Ultrasound Med Biol. 2003;29:555–562
  69. Horvath KA, Smith WJ, Laurence RG, Schoen FJ, Appleyard RF, Cohn LH. Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularisation. J Am Coll Cardiol. 1995;25:258–263
  70. Cooley DA, Frasier OH, Kadipasaoglu KA, Lindenmeir MH, Pehlivanoglu S, Kolff JW, et al. Transmyocardial laser revascularisation: clinical experience with twelve-month follow-up. J Thorac Cardiovasc Surg. 1996;111:791–799
  71. Klein M, Schulte HD, Gams E. TMLR management of coronary artery diseases. Berlin: Springer; 1998;
  72. Lange RA, Hillis LD. Transmyocardial laser revascularisation. N Engl J Med. 1999;341:1075–1076
  73. Horvath KA, Manning F, Cummings N, Shernan SK, Cohn LH. Transmyocardial laser revascularisation: operative techniques and clinical results at two years. J Thorac Cardiovasc Surg. 1996;111:1047–1053
  74. Brinkmann R, Theisen D, Brendel T, Birngruber R. Single-pulse 30-J holmium laser for myocardial revascularization—a study on ablation dynamics in comparison to CO2 laser-TMR. IEEE J Selected Topics Quantum Electron. 1999;5:1–2
  75. Vogel A, Venugopalan V. Mechanisms of pulsed laser ablation of biological tissues. Chem Rev. 2003;103:577–644
  76. Van Leeuwen TG, van Erven L, Meerten JH, Motamedi M, Post MJ, Borst C. Origin of arterial wall dissections induced by pulsed excimer and mid-infrared laser ablation in the pig. J Am Coll Cardiol. 1992;19:1610–1618
  77. Brujan EA, Nahen K, Schmidt P, Vogel A. Dynamics of laser-induced cavitation bubbles near an elastic boundary. J Fluid Mech. 2001;433:251–281
  78. Brujan EA, Nahen K, Schmidt P, Vogel A. Dynamics of laser-induced cavitation bubbles near elastic boundaries: influence of the elastic modulus. J Fluid Mech. 2001;433:283–314
  79. Brujan EA, Vogel A. Stress wave emission and cavitation bubble dynamics by nanosecond optical breakdown in a tissue phantom. J Fluid Mech. 2006;558:281–308
  80. Von Knobelsdorff G, Braur P, Tonner PH, Hännel F, Naegele H, Stubbe HM, et al. Transmyocardial laser revascularisation induces cerebral microembolisation. Anesthesiology. 1997;87:58–62
  81. Feinstein SB, Shah PM, Bing RJ, Meebaum S, Corday E, Chang BL, et al. Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol. 1984;4:595–600
  82. Gerriets T, Grossherr M, Misfeld M, Nees U, Reusche E, Stolz E, et al. Strategies for the reduction of cerebral microembolism during transmyocardial laser revascularisation. Laser Surg Med. 2004;34:79–384
  83. Bittl JA. Advances in coronary angioplasty. N Engl J Med. 1996;335:1290–1302
  84. Bittl JA, Ryan TJ, Keaney JF, Tcheng JE, Ellis SG, Isner JM, et al. Coronary artery perforation during excimer laser coronary angioplasty. J Am Coll Cardiol. 1993;21:1158–1165
  85. Rosenschein U, Rozenzsajn LA, Kraus L, Marboe CC, Watkins JF, Rose EA, et al. Ultrasonic angioplasty in totally occluded peripheral arteries Initial clinical histological and angiographic results. Circulation. 1991;83:1976–1986
  86. Lee G, Mason DT. Excimer coronary laser angioplasty—its time for a critical evaluation. Am J Cardiol. 1992;69:1640–1643
  87. Safian RD, Niazi KA, Strzelecki M, Lichtenberg A, May MA, Juran N, et al. Detailed angiographic analysis of high-speed mechanical rotational atherectomy in human coronary arteries. Circulation. 1993;88:961–968
  88. Demer LL, Ariani M, Siegel RJ. High intensity ultrasound increases distensibility of calcific atherosclerotic arteries. J Am Coll Cardiol. 1991;18:1259–1262
  89. Haude M, Welge D, Koch L, Roth T, Ge J, Baumgart D, et al. Laser angioplasty and laser recanalization. Herz. 1997;22:299–307
  90. Appelman YEA, Piek JJ, Strikwerda S, Tijssen JGP, de Feyter PJ, David GK, et al. Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease. Lancet. 1996;347:79–84
  91. Mintz GS, Kovach JA, Javier SP, Pichard AD, Kent KM, Popma JJ, et al. Mechanisms of lumen enlargement after excimer laser coronary angioplasty: an intravascular ultrasound study. Circulation. 1995;92:3408–3414
  92. Baumbach A, Bittl JA, Fleck E, Geschwind HJ, Sanborn TA, Tcheng JE. Acute complications of excimer laser coronary angioplasty: a detailed analysis of multicenter results. J Am Coll Cardiol. 1994;23:1305–1313
  93. Van Leeuwen TG, Meertens JH, Velema E, Post MJ, Borst C. Intraluminal vapor bubble induced by excimer laser pulse causes microsecond arterial dilation and invagination leading to extensive wall damage in the rabbit. Circulation. 1993;87:1258–1263
  94. Oberhoff M, Hassenstein S, Hanke H, Xie DY, Blessing E, Baumbach A, et al. Smooth excimer laser coronary angioplasty (SELCA)—initial experimental results. Circulation. 1992;86:800
  95. Haase KK, Rose C, Duda S, Baumbach A, Oberhoff M, Anthanasiadis A, et al. Perspectives of coronary excimer laser angioplasty: multiplexing saline flushing and acoustic ablation control. Lasers Surg Med. 1997;21:72–79
  96. Litvack F, Eigler NL, Forrester JS. In search of the optimized excimer laser angioplasty system. Circulation. 1993;87:1421–1422
  97. Van Leeuwen TG, Janse ED, Welch AJ, Borst C. Excimer laser induced bubble: dimensions theory and implications for laser angioplasty. Lasers Surg Med. 1996;18:381–390
  98. Van Leeuwen TG, Velema E, Pasterkamp G, Post MJ, Borst C. Saline flush during excimer laser angioplasty: short and long term effects in the rabbit femoral artery. Lasers Surg Med. 1998;23:128–140
  99. Vogel A, Engelhardt R, Behnle U, Parlitz U. Minimization of cavitation effects in pulsed laser ablation illustrated on laser angioplasty. Appl Phys B. 1996;62:173–182
  100. Vogel A, Schmidt P, Flucke B. Minimization of thermo-mechanical side effects in IR ablation by use of Q-switched double pulses. Proc SPIE. 2001;4257:184–191
  101. Vogel A, Schmidt P, Flucke B. Minimization of thermomechanical side effects and increase in ablation efficiency in IR ablation by use of multiply Q-switched laser pulses. Proc SPIE. 2002;4617:105–111
  102. Zotz RJ, Erbel R, Philipp A, Judt A, Wagner H, Lauterborn W, et al. High-speed rotational angioplasty-induced echo contrast in vivo and in vitro optical analysis. Catheter Cardiovasc Diagn. 1992;26:98–109
  103. Johansen P. Mechanical heart valve cavitation. Exp Rev Med Dev. 2004;1:95–104
  104. Zubarev RP, Kolpakov EV, Morov GV, Gabeskiriia RI. Problems of thrombogenesis and destruction of the superficial layer of implanted artificial heat valves. Med Tekh. 1976;4:26–29
  105. Deuvaert FE, Devriendt J, assaut J, van Nooten G, de Paepe J, Primo G. Leaflet escape of a mitral Duromedics prosthesis. Case report. Acta Chir Belg. 1989;89:15–18
  106. Alvarez J, Deal CW. Leaflet escape from a Duromedics valve. J Thorac Cardiovasc Surg. 1990;99:372
  107. Graf T, Fischer H, Reul H, Rau G. Cavitation potential of mechanical heart valve prostheses. Int J Artif Organs. 1991;14:169–174
  108. Kafesjian R, Howannec M, Ward GD, Diep L, Wagstaff LS, Rhee R. Cavitation damage of pyrolytic carbon in mechanical heart valves. J Heart Valve Dis. 1994;3:S2–S7
  109. Takiura K, Chinzei T, Abe Y, Isoyama T, Saito I, Ozeki T, et al. A new approach to detection of the cavitation on mechanical heart valves. ASAIO J. 2003;49:304–308
  110. Wu SZ, Gao BZ, Hwang NH. Transient pressure at closing of a monoleaflet mechanical heart valve prosthesis: mounting compliance effect. J Heart Valve Dis. 1995;4:553–567
  111. Chandran KB, Aluri S. Mechanical valve closing dynamics: relationship between velocity of closing pressure transients and cavitation initiation. Ann Biomed Eng. 1997;25:926–938
  112. Zapanta CM, Stinebring DR, Sneckenberger DS, Deutsch S, Geselowitz DB, Tarbell JM, et al. In vivo observation of cavitation on prosthetic heart valves. ASAIO J. 1996;42:M550–M555
  113. Garrison LA, Lamson TC, Deutsch S, Geselowitz DB, Gaumond RP, Tarbell JM. An in vitro investigation of prosthetic heart valve cavitation in blood. J Heart Valve Dis. 1994;3:S8–S24
  114. Paulsen PK, Jensen BK, Hasenkam JM, Nygaard H. High-frequency pressure fluctuations measured in heart valve patients. J Heart Valve Dis. 1999;8:482–486
  115. Andersen TS, Johansen P, Paulsen PK, Nygaard H, Hasenkam JM. Indication of cavitation in mechanical heart valve patients. J Heart Valve Dis. 2003;12:790–796
  116. Wu SZ, Shu MC, Scott DR, Hwang NH. The closing behaviour of Medtronic Hall mechanical heart valves. ASAIO J. 1994;40:M702–M706
  117. Zhang P, Yeo JH, Hwang NHC. Development of squeeze flow in mechanical heart valve: a particle image velocimetry investigation. ASAIO J. 2006;52:391–397
  118. Lee H, Taenaka Y. Mechanism for cavitation phenomenon in mechanical heart valves. J Mech Sci Technol. 2006;20:1118–1124
  119. Zapanta CM, Stinebring DR, Deutsch S, Geselowitz DB, Tarbell JM. A comparison of the cavitation potential of prosthetic heart valves based on valve closing dynamics. J Heart Valve Dis. 1998;7:655–667
  120. Avrahami I, Rosenfeld M, Einav S, Eicher M, Reul H. Can vortices in the flow across mechanical heart valves contribute to cavitation?. Med Biol Eng Comput. 2000;38:93–97
  121. Manning KB, Kini V, Fontaine AA, Deutsch S, Tarbell JM. Regurgitant flow field characteristics of the St Jude bileaflet mechanical heart valve under physiological pulsatile flow using particle image velocimetry. Artif Organs. 2003;27:840–846
  122. Rambod E, Beizai M, Sahn DJ, Gharib M. Role of vortices in growth of microbubbles at mitral mechanical heart valve closure. Ann Biomed Eng. 2007;35:1131–1145
  123. Hwang NH. Cavitation potential of pyrolytic carbon heart valve prostheses: a review and current status. J Heart Valve Dis. 1998;7:140–150
  124. Klepetko W, Moritz A, Mlczoch J, Schurawitzki H, Domanig E, Wolner E. Leaflet fracture in Edwars-Duromedics bileaflet valves. J Thorac Cardiovasc Surg. 1989;97:90–94
  125. Nötzold A, Khattab AA, Eggers J. Microemboli in aortic valve replacement. Expert Rev Cardiovasc Ther. 2006;4:853–859
  126. Levy DJ, Child JS, Rambod E, Gharib M, Milo S, Reisner SA. Microbubbles and mitral valve prostheses—transesophageal echocardiographic evaluation. Eur J Ultrasound. 1999;10:31–40
  127. Girod G, Jaussi A, Rosset C, de Werra P, Hirt F, Kappenberger L. Cavitation versus degassing: in vitro study of the microbubble phenomenon observed during echocardiography in patients with mechanical prosthetic cardiac valves. Echocardiography. 2002;19:531–536
  128. Biancucci BA, Deutsch S, Geselowitz DB, Tarbell JM. In vitro studies of gas bubble formation by mechanical heart valve. J Heart Valve Dis. 1999;8:186–196
  129. Milo S, Rambod E, Gutfinger C, Gharib M. Mitral mechanical heart valves: in vitro studies of their closure vortex and microbubble formation with possible medical implications. Eur J Cardiothorac Surg. 2003;24:364–370
  130. Bachmann C, Kini V, Deutsch S, Fontaine AA, Tarbell JM. Mechanisms of cavitation and the formation of stable bubbles on the Bjork-Shiley Monostrut prosthetic heart valve. J Heart Valve Dis. 2002;11:105–113
  131. Potthast K, Erdonmez G, Schnelke C, Sellin L, Sliwka U, Schondube F, et al. Origin and appearance of HITS induced by prosthetic heart valves: an in vitro study. Int J Artif Organs. 2000;23:441–445
  132. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation. 2003;107:973–977
  133. Kripfgans OD, Fowlkes JB, Miller DL, Eldevik OP, Carson PL. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultrasound Med Biol. 2000;26:1177–1189
  134. Ye T, Bull JL. Direct numerical simulations of micro-bubble expansion in gas embolotherapy. J Biomech Eng. 2004;126:745–759
  135. Calderon AJ, Heo YS, Huh D, Futai N, Takayama S, Fowlkes JB, et al. Microfluidic model of bubble lodging in microvessel bifurcations. Appl Phys Lett. 2006;89:244103
  136. Ye T, Bull JL. Microbubble expansion in a flexible tube. J Biomech Eng. 2006;128:554–563

PII: S1350-4533(09)00078-2

doi: 10.1016/j.medengphy.2009.03.007

Medical Engineering & Physics
Volume 31, Issue 7 , Pages 742-751 , September 2009